Search This Blog

Thursday, October 31, 2019

Eidos Therapeutics EPS of $0.18

Eidos Therapeutics (NASDAQ:EIDX): Q3 EPS of $0.18 may not be comparable to consensus of -$0.27.
Revenue of $26.69M beats by $24.61M.
Press Release
Posted by at

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.

Subscribe to: Post Comments (Atom)